Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tanzania Consults On East African Community Guidelines, Including For Biosimilars

Executive Summary

The Tanzanian drug regulator is holding a stakeholder workshop on Jan. 25 to discuss the adoption of various guidelines drafted by medicines experts within the East African Community network. On the list of documents to be discussed is a draft guideline on the registration of biosimilars.

You may also be interested in...

Plans For East African Drug Regulator Begin To Take Shape

A report by the European Medicines Agency and the regulators from the East African Community has outlined the possible shape of a regional regulator in east Africa.

UK To Reveal How Sponsors Are Performing On Trial Transparency Expectations

The UK is tightening its approach to enforcing best practices in clinical trial transparency.

New EU Clinical Trials System Could Support Patient Recruitment

The EU research-based pharma industry is exploring partnerships to develop an app that would extract data from the new Clinical Trial Information System and convert it into lay format to guide patients interested in participating in studies. 





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts